Expert calls pegloticase a powerhouse gout drug not to be feared
Posted on: 03/02/2014 - 14:25
SNOWMASS, COLO. – Pegloticase (Krystexxa) is a gout drug that’s expensive, inconveniently administered by intravenous infusion every 2 weeks, and saddled with a substantial rate of immunogenicity,...
Field of Interest: Rheumatology
Type: News Item